Edenwell has successfully partnered with international pharmaceutical and biotechnology sponsors across multiple geographies, providing end-to-end CRO services that qualify as exports of clinical research from India.
Our international track record demonstrates our ability to deliver globally compliant clinical trial services even in complex operating environments.
Edenwell’s international credentials include the successful execution of a global Phase III oncology clinical trial in India for a large international pharmaceutical sponsor. This landmark engagement involved:
The engagement was delivered despite significant external challenges and generated direct foreign exchange inflows into India, classifying Edenwell as a high-value MSME contributing to India’s service export economy.
Partnership across multiple continents and regions
Proven success with international audits and regulatory approvals
75+ investigator sites evaluated across India for global studies
Long-term relationships with leading pharma and biotech companies
Generating foreign exchange through high-quality clinical research exports
Edenwell currently maintains an active pipeline of international clinical research proposals across multiple therapeutic areas, including oncology and immunology, at advanced stages of commercial negotiation with international sponsors.
